Atlas Trials

Study of Sargramostim in Patients With COVID-19

Clinical trial NCT04411680 · COMPLETED

Trial details

NCT number
NCT04411680
Sponsor
Partner Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19SARS-CoV-2
Start date
2020-08-18
Primary completion
2021-03-02
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.